Concepedia

Lanlan Song

LS

Statistics

Publications

4

Citations

62

H-Index

4

Active since

2022

Affiliations

First Affiliated Hospital of Wenzhou Medical University(Current)

Wenzhou Medical University

Lanlan Song is an author at First Affiliated Hospital of Wenzhou Medical University specializing in peroxisome proliferator receptor signaling, pulmonary hypertension, and non-small cell lung cancer therapy.

Publications per year

2022–2024

4

Publications

4

Parthenolide attenuates hypoxia-induced pulmonary hypertension through inhibiting STAT3 signaling

Yizhu Yao, Lanlan Song, Ziyi Zuo et al. · Phytomedicine · 2024 · 19 citations · Full text

, , +14

FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ

Meibin Wang, Lihuang Su, Junwei Sun et al. · Journal of Cellular and Molecular Medicine · 2022 · 18 citations · Full text

, , +17

Fe-Based Metal–Organic Frameworks with Ferroptosis Generation Ability for Remodeling Chemotherapy of Non-small Cell Lung Cancer

Ying‐Li Luo, Xiaoming Yu, Yizhu Yao et al. · ACS Applied Nano Materials · 2023 · 13 citations

, , +17

Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation

Xiuchun Li, Xiayan Zhu, Yangyue Wang et al. · Acta Pharmacologica Sinica · 2024 · 12 citations · Full text

, , +17

1–4 of 4